NEWARK, N.J., Aug. 12 BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology-based Life Science company announced today that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) Hospital Grade formula delivered a 100% Total Kill of over one million live Clostridium Sporogenes spores in a four (4) minute time frame - performance which is up to 75 times faster than competitive products such as Steris(R) Spor-Klenz RTU.
"The company is in discussions with a global leader in the health care sector to arrange distribution following our regulatory approval," said Stephen J. Browand, CEO BioNeutral Group Inc. "Our health care market alone is very broad and includes every hospital, nursing home, home health care patient, every immune suppressed patient, emergency room, ambulance, first responder, and doctor, dental, and veterinary office."
"Whether it is the present Swine Flu (H1N1) pandemic or the most difficult to kill dangerous organisms, Bioneutral's technology has given rise to the only family of sporicidal formulations for the hospital/health care sector, industry (including schools) and the home. Performance is unsurpassed, it has a Green environmental profile, is non corrosive, non staining to most fabrics (eg sheets and pillow cases) and can come into contact with skin while remaining sporicidal," said Dr Andy Kielbania PhD, BioNeutral's Chief Scientific Officer.
This EPA required AOAC Sporicidal Test utilizing spore impregnated knotted suture loops is an extremely difficult test to pass especially when starting with over one million Clostridium Sporogenes spores. The rapid elimination of these health threatening microorganisms at health care facilities will reduce the incidents of Hospital Acquired Infections (ACI) and the associated loss of lives. Many of today's best known industrial disinfectants, including those commonly used in hospitals and health care facilities, are unable to pass this test at all or require up to several hours of direct wet contact to pass.
Examples of commonly used antimicrobials in health care facilities which cannot claim passing this EPA sporicide/sterilant test include CaviCide(R) and Medica DC 10(TM). While these antimicrobials may eliminate easily eradicated bacteria and some viruses, they have no effect on spores and therefore cannot claim to be sporicidal. Examples of antimicrobials which have passed the EPA required test include Actril(R) Cold Sterilant and Clidox(R)(R)-S which require hours to be effective. Steris(R) Hydrogen Peroxide Sterilant requires special protective equipment and highly trained professionals to correctly apply this antimicrobial. In addition this product requires 90 minutes of direct contact to eliminate spores. Steris(R) Spor-Klenz RTU is easier to apply but can take up to five and one half hours (5.5 hours) to eliminate spores.
A sporicide/sterilant which operates at room temperature with the rapid kill demonstrated by Ygiene(TM) Hospital Grade will provide a substantial economic advantage for future users. Ygiene is easy to use and provides a much quicker turn around time for total sterilization of equipment and facilities. BioNeutral's Ygiene(TM) will reduce the cost of human resources and capital expenditure, decrease turnaround time for surgical procedures and medical facilities thereby maximizing precious resources while providing increased safety for staff and patients alike.
About ATS Labs:
ATS Labs, http://www.ats-labs.com is a leading internationally recognized lab used by the developers and users of antimicrobial products. They provide comprehensive antimicrobial service and their superior client service and scientific data have earned them a distinguished record of acceptance with regulatory agencies in the U.S., Canada and the world.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
More information about the Company may be found at www.bioneutralgroup.com
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
BioNeutral Group Inc. Stephen J. Browand, President and CEO [email protected]
Investor Relations Aimee Boutcher 973 239-2878 [email protected]
SOURCE BioNeutral Group, Inc.